Literature DB >> 12492758

Supply control and harm reduction: lessons from the Australian heroin 'drought'.

Don Weatherburn1, Craig Jones, Karen Freeman, Toni Makkai.   

Abstract

AIMS: To examine the effects of supply-side drug law enforcement on the dynamics of the Australian heroin market and the harms associated with heroin.
SETTING: Around Christmas 2000, heroin users in Sydney and other large capital cities in Australia began reporting sudden and significant reductions in the availability of heroin. The changes, which appear to have been caused at least in part by drug law enforcement, provided a rare opportunity to examine the potential impact of such enforcement on the harm associated with heroin.
DESIGN: Data were drawn from a survey of 165 heroin users in South-Western Sydney, Australia; from the Drug Use Monitoring in Australia (DUMA) project; from NSW Health records of heroin overdoses; and from the Computerized Operational Policing System (COPS) database.
FINDINGS: Heroin price increased, while purity, consumption and expenditure on the drug decreased as a result of the shortage. The fall in overall heroin use was accompanied by a significant reduction in the rate of overdose in NSW. However, the health benefits associated with the fall in overdose may have been offset by an increase in the use of other drugs (mainly cocaine) since the onset of the heroin shortage. There does not appear to have been any enduring impact on crime rates as a result of the heroin 'drought'.
CONCLUSION: Supply control has an important part to play in harm reduction; however, proponents of supply-side drug law enforcement need to be mindful of the unintended adverse consequences that might flow from successfully disrupting the market for a particular illegal drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492758     DOI: 10.1046/j.1360-0443.2003.00248.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  22 in total

1.  Drug supply and drug abuse.

Authors:  Michael Copeman
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

Review 2.  What economics can contribute to the addiction sciences.

Authors:  Jonathan P Caulkins; Nancy Nicosia
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

3.  Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.

Authors:  Elisa Lloyd-Smith; Evan Wood; Kathy Li; Julio S G Montaner; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2008-09-20       Impact factor: 4.492

4.  Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs.

Authors:  Dan Werb
Journal:  Int J Drug Policy       Date:  2017-07-19

5.  Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform.

Authors:  Dan Werb; Steffanie A Strathdee; Emilo Meza; Maria Gudelia Rangel Gomez; Lawrence Palinkas; Maria Elena Medina-Mora; Leo Beletsky
Journal:  Glob Public Health       Date:  2015-12-13

6.  The War on Drugs: Methamphetamine, Public Health, and Crime.

Authors:  Carlos Dobkin; Nancy Nicosia
Journal:  Am Econ Rev       Date:  2009-03-01

7.  A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Eur J Epidemiol       Date:  2017-12-12       Impact factor: 8.082

8.  Impact of South American heroin on the US heroin market 1993-2004.

Authors:  Daniel Ciccarone; George J Unick; Allison Kraus
Journal:  Int J Drug Policy       Date:  2009-02-06

9.  Heroin in brown, black and white: structural factors and medical consequences in the US heroin market.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2008-10-21

10.  Can abuse deterrent formulations make a difference? Expectation and speculation.

Authors:  Simon H Budman; Jill M Grimes Serrano; Stephen F Butler
Journal:  Harm Reduct J       Date:  2009-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.